1. Home
  2. GGR vs NTRB Comparison

GGR vs NTRB Comparison

Compare GGR & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gogoro Inc.

GGR

Gogoro Inc.

N/A

Current Price

$2.90

Market Cap

47.7M

ML Signal

N/A

Logo Nutriband Inc.

NTRB

Nutriband Inc.

HOLD

Current Price

$4.27

Market Cap

57.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGR
NTRB
Founded
2011
2016
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.7M
57.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GGR
NTRB
Price
$2.90
$4.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.7K
16.7K
Earning Date
02-12-2026
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$280,211,000.00
$2,278,321.00
Revenue This Year
N/A
$30.17
Revenue Next Year
$6.15
$3,394.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.69
52 Week Low
$2.72
$4.17
52 Week High
$10.15
$11.68

Technical Indicators

Market Signals
Indicator
GGR
NTRB
Relative Strength Index (RSI) 37.56 41.69
Support Level $3.14 $4.51
Resistance Level $3.20 $4.85
Average True Range (ATR) 0.16 0.29
MACD -0.01 0.00
Stochastic Oscillator 0.00 8.97

Price Performance

Historical Comparison
GGR
NTRB

About GGR Gogoro Inc.

Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: